The stock price of Dynavax Technologies Corporation (NASDAQ: DVAX) – a biopharmaceutical company focused on developing and commercializing novel vaccines – increased by over 9% pre-market as of 8:13 AM ET. The average price from analysts is $18.00. DVAX, Dynavax Technologies - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Dynavax Technologies Stock Quote: DVAX Stock News, Quotes, Analysis | Investors.com Today, the average trading volume of DVAX was 6.18M shares. Burgess Justin, the Principal Accounting Officer of Dynavax Technologies Corporation, sale 2,958 shares at $8.88 during a trade that took place back on Mar 01, which means that Burgess Justin is holding 8,175 shares at $26,267 based on the most recent closing price. DVAX is a Stock that could be massively shorted. DVAX stocks went up by 14.46% for the week, with a monthly drop of -8.54% and a quarterly performance of 98.67%, while its annual performance rate touched 215.80%. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company. Equity multiplier, or assets relative to shareholders' equity, comes in at 6.54 for Dynavax Technologies Corp; that's greater than it is for 82.46% of US stocks. We Know the Answer. 2,775,706 shares traded hands during mid-day trading, a decline of 61% from the average session volume of 7,097,527 shares. Dynavax Technologies Corporation, which has a market valuation of $1.05 Billion, is expected to release its quarterly earnings report on February 25, 2021. It’s free. You have entered an incorrect email address! The stock options were granted on February 1, 2021 at an exercise price of $10.27 per share, which is equal to the closing price of Dynavax (DVAX) common stock on the date of grant. Dynavax Technologies Corporation (DVAX) stock is trading at $10.78 as of 1:23 PM on Monday, Feb 8, a rise of $1.30, or 13.71% from the previous closing price of $9.48. Volatility was left at 9.13%, however, over the last 30 days, the volatility rate increased by 8.56%, as shares sank -1.27% for the moving average over the last 20 days. The rating they have provided for DVAX stocks is “Buy” according to the report published on August 03rd, 2020. Get Best Morning Financial Newsletter... 100% Free. Next 151 results. Shares of Dynavax Technologies (NASDAQ: DVAX) were soaring 18.8% as of 10:50 a.m. EST on Friday. After this action, Burgess Justin now owns 7,010 shares of Dynavax Technologies Corporation, valued at $10,275 using the latest closing price. What this means: Dynavax Technologies (DVAX) gets an Overall Rank of 73, which is an above average rank under InvestorsObserver's stock ranking system. It has oscillated between 1 and 4. The company have seen two... Related searches. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! NewsHeater is specialized on the investments in tech sphere. Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that Ryan Spencer, Chief Executive Officer, will present at the H.C. Wainwright Virtual 2021 Global Life Sciences Conference being held March 9-10, 2021. DVAX Stock Summary With a price/sales ratio of 20.61, Dynavax Technologies Corp has a higher such ratio than 90.79% of stocks in our set. Dynavax (DVAX) was granted the approval after getting a positive opinion from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP). See
Previously, the target price had yet another raise to $14, while Evercore ISI analysts kept a Outperform rating on DVAX stock. DVAX's rank also includes a fundamental score of 88. Boards. Many brokerage firms have already submitted their reports for DVAX stocks, with H.C. Wainwright repeating the rating for DVAX by listing it as a “Buy.” The predicted price for DVAX in the upcoming period, according to H.C. Wainwright is $12 based on the research report published on August 07th of the previous year 2020. Finance; Good News For Dynavax Technologies Corporation (NASDAQ:DVAX): Stock Could Rise Another 105.34%. Find the latest Dynavax Technologies Corporatio (DVAX) stock quote, history, news and other vital information to help you with your stock trading and investing. Here’s what’s going … Following the sale, the insider now directly owns 1,221 shares of the company’s stock, valued at $10,842.48. We have 9 different ratings for every stock to help you
GKP Gulf … The most mentioned tickers in articles about DVAX are. © Copyright - Newspaper WordPress Theme by TagDiv, Get The Best Stocks To Trade Every Day!...100% Free. Trending Now. The volatility ratio for the week stands at 8.56% while the volatility levels for the past 30 days are set at 9.13% for Dynavax Technologies Corporation. 8.18-0.29 (-3.42%) Upgrade to Real-Time Afterhours ... DVAX) Intraday Stock Chart Friday 5 March 2021 Your Recent History LSE. Just click the link
by Joshua Rodriguez; May 19, 2020 May 19, 2020; Dynavax Technologies Corporation (NASDAQ: DVAX) is rocketing early this morning, trading on gains of more than 40%. Kailas Salunkhe on TipRanks | February 21, 2021. The volatility ratio for the week stands at 8.56% while the volatility levels for the past 30 days are set at 9.13% for Dynavax Technologies Corporation. Looking for insights on Dynavax (NCM:DVAX) stock? Dynavax Technologies News: This is the News-site for the company Dynavax Technologies on Markets Insider . The approval is based on positive risk-benefit for the vaccine backed by results from three Phase 3 trials. DVAX, Dynavax Technologies - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Dynavax Technologies Stock Quote: DVAX Stock News, Quotes, Analysis | Investors.com Volume today is 6,389,837 compared to average volume of 8,017,187. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing. Return. DYNAVAX TECHNOLOGIES AKTIE und aktueller Aktienkurs. TradingView . The current RSI for DVAX stock in for the last two-week period is set at 47.42, with the RSI for the last a single of trading hit 40.73, and the three-weeks RSI is set at 51.19 for Dynavax Technologies Corporation [DVAX]. Can Vertex Energy Inc. (VTNR) Remain Competitive? The stock options were granted on February 1, 2021 at an exercise price of $10.27 per share, which is equal to the closing price of Dynavax (DVAX) common stock on the date of grant. Dynavax Technologies Corporation DVAX was a big mover last session, as the company saw its shares rise nearly 7% on the day. Why Dynavax Stock Is Skyrocketing Today: 150: The Motley Fool: 01.02. View the real-time DVAX price chart on Robinhood and decide if you want to buy or sell commission-free. S&P. The gains come after an SEC filing was made public, suggesting that the company’s COVID-19 vaccine will be headed into human trials. by Joshua Rodriguez; May 19, 2020 May 19, 2020; Dynavax Technologies Corporation (NASDAQ: DVAX) is rocketing early this morning, trading on gains of more than 40%. Opinions of the stock are interesting as 4 analysts out of 4 who provided ratings for Dynavax Technologies Corporation declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”, The 2021 Backdoor Crypto Portfolio (free). Twitter. Stocks; Commodities; Forex; Cryptocurrency; The Lounge; Hot! DVAX News Highlights DVAX's 30 day story count now stands at 30. Find the latest news headlines from Dynavax Technologies Corporation Common Stock (DVAX) at Nasdaq.com. Over the last 50 days, in opposition, the stock is trading +97.86% upper at present.